Screener
AngioDynamics ANGO Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Principal payments on financing arrangement | (375) | (148) | — |
| Proceeds from financing arrangement | — | 6,310 | — |
| Payment of acquisition related contingent consideration | — | (5,000) | (15,000) |
| Repurchase of common stock | — | (1,670) | — |
| Proceeds from exercise of stock options and employee stock purchase plan | 939 | 933 | 752 |
| Net cash provided by (used in) financing activities | 564 | (255) | (64,248) |
| Effect of exchange rate changes on cash and cash equivalents | 267 | 398 | 125 |
| Increase (decrease) in cash and cash equivalents | (2,029) | (20,163) | 31,436 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's share buybacks?
- AngioDynamics (ANGO) reported share buybacks of $0 in Q1 2026.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.
Ask your AI about AngioDynamics's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude